Expansion of Vancomycin-Resistant


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
05 2019
Historique:
received: 18 09 2018
accepted: 13 02 2019
pubmed: 21 2 2019
medline: 31 3 2020
entrez: 21 2 2019
Statut: epublish

Résumé

Vancomycin-resistant

Identifiants

pubmed: 30782988
pii: AAC.01978-18
doi: 10.1128/AAC.01978-18
pmc: PMC6496047
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Clin Infect Dis. 2017 Apr 1;64(7):886-893
pubmed: 28362945
Int J Hyg Environ Health. 2004 Sep;207(4):386-9
pubmed: 15471103
Am J Infect Control. 2015 Oct 1;43(10):1061-5
pubmed: 26190380
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W347-52
pubmed: 21672955
J Antimicrob Chemother. 2017 Jan;72(1):40-47
pubmed: 27605596
Heliyon. 2017 Dec 28;3(12):e00473
pubmed: 29322099
Clin Infect Dis. 2005 Aug 1;41(3):327-33
pubmed: 16007529
Euro Surveill. 2012 Jul 26;17(30):
pubmed: 22856512
BMC Genomics. 2014 Aug 29;15:737
pubmed: 25168460
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
J Antimicrob Chemother. 2014 Jun;69(6):1660-4
pubmed: 24615816
Emerg Infect Dis. 2008 Feb;14(2):317-9
pubmed: 18258130
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Antimicrob Chemother. 2008 May;61(5):1033-9
pubmed: 18319236
Clin Microbiol Infect. 2009 Mar;15(3):212-7
pubmed: 19335368
Sci Rep. 2016 Feb 23;6:21847
pubmed: 26902259
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Clin Microbiol Infect. 2013 Apr;19(4):E181-9
pubmed: 23398607
Braz J Infect Dis. 2011 Jul-Aug;15(4):403-5
pubmed: 21861018
Infect Control Hosp Epidemiol. 2016 Mar;37(3):289-94
pubmed: 26669221
Clin Infect Dis. 1999 Sep;29(3):573-9
pubmed: 10530450
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1221-36
pubmed: 25199988
J Infect Dis. 2010 Oct 15;202(8):1278-86
pubmed: 20812846
J Comput Biol. 2013 Oct;20(10):714-37
pubmed: 24093227
Genome Biol Evol. 2013;5(8):1524-35
pubmed: 23882129
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Am J Infect Control. 2008 Apr;36(3):206-11
pubmed: 18371517
Clin Microbiol Infect. 2006 Feb;12(2):163-9
pubmed: 16441455
J Clin Microbiol. 1998 Aug;36(8):2187-90
pubmed: 9665988
J Antimicrob Chemother. 2015 Sep;70(9):2474-82
pubmed: 26031466
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
Bioinformatics. 2015 Feb 15;31(4):587-9
pubmed: 25338718
Infect Control Hosp Epidemiol. 2008 Jul;29(7):583-9
pubmed: 18549314

Auteurs

Jan Liese (J)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany jan.liese@med.uni-tuebingen.de silke.peter@med.uni-tuebingen.de.
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Leonard Schüle (L)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.

Philipp Oberhettinger (P)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Leonie Tschörner (L)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.

Tran Nguyen (T)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.

Daniela Dörfel (D)

Medical Center, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University of Tübingen, Tübingen, Germany.
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.

Wichard Vogel (W)

Medical Center, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University of Tübingen, Tübingen, Germany.

Matthias Marschal (M)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Ingo Autenrieth (I)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Matthias Willmann (M)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Silke Peter (S)

Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany jan.liese@med.uni-tuebingen.de silke.peter@med.uni-tuebingen.de.
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH